ADIL - ADIAL PHARMACEUTICALS, INC.
2.29
-0.180 -7.860%
Share volume: 1,647,221
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.15%
PREVIOUS CLOSE
CHG
CHG%
$2.47
-0.18
-0.07%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-13-2024 | 11-13-2024 | 03-04-2025 | 05-14-2025 | 08-13-2025 | 11-13-2025 | |
| Assets | ||||||||
| Total Assets | 6.684 M | 4.949 M | 6.713 M | 5.044 M | 3.451 M | 6.802 M | 5.660 M | |
| Current Assets | 5.336 M | 3.823 M | 5.619 M | 4.059 M | 2.629 M | 6.079 M | 5.014 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 5.025 M | 3.288 M | 5.204 M | 3.751 M | 2.366 M | 5.915 M | 4.606 M | |
| Total Non-current Assets | 1.344 M | 1.122 M | 1.091 M | 981.830 K | 818.740 K | 720.010 K | 643.090 K | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 1.348 M | 1.125 M | 1.094 M | 985.178 K | 821.947 K | 723.076 K | 646.015 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 6.684 M | 4.949 M | 6.713 M | 5.044 M | 3.451 M | 6.802 M | 5.660 M | |
| Total liabilities | 562.731 K | 671.882 K | 829.046 K | 975.858 K | 1.324 M | 1.211 M | 1.155 M | |
| Total current liabilities | 562.731 K | 671.882 K | 829.046 K | 975.858 K | 1.324 M | 1.211 M | 1.155 M | |
| Accounts Payable | 177.468 K | 316.726 K | 318.118 K | 298.402 K | 565.765 K | 671.118 K | 556.284 K | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 6.122 M | 4.277 M | 5.884 M | 4.068 M | 2.127 M | 5.591 M | 4.505 M | |
| Common stock | 81.396 M | 82.010 M | 85.808 M | 86.063 M | 86.351 M | 91.773 M | 92.481 M | |
| Retained earnings | -75.274 M | -77.733 M | -79.925 M | -81.995 M | -84.224 M | -86.183 M | -87.976 M |